HBK Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-39,500
Closed -$1.91M 844
2016
Q3
$1.91M Buy
39,500
+17,885
+83% +$905K 0.02% 381
2016
Q2
$1.2M Buy
21,615
+16,495
+322% +$909K 0.01% 527
2016
Q1
$273K Sell
5,120
-7,080
-58% -$349K ﹤0.01% 847
2015
Q4
$628K Buy
12,200
+6,500
+114% +$323K 0.01% 695
2015
Q3
$257K Buy
+5,700
New +$269K ﹤0.01% 890
2014
Q2
Sell
-33,328
Closed -$908K 1005
2014
Q1
$908K Sell
33,328
-5,666
-15% -$168K 0.02% 522
2013
Q4
$1.4M Sell
38,994
-8,006
-17% -$266K 0.03% 376
2013
Q3
$1.42M Buy
47,000
+22,100
+89% +$723K 0.02% 374
2013
Q2
$726K Buy
+24,900
New +$702K 0.01% 481

Other funds holding PBH

HBK Investments's PBH Position: Q4 2016 in Review

HBK Investments sold out of Prestige Consumer Healthcare (PBH) in Q4 2016, closing a stake of 39,500 shares — an estimated $1.91M sold.

HBK Investments first reported a position in PBH in Q2 2013 and held it in 9 quarters. The position peaked at $1.91M in Q3 2016. 238 funds tracked by Wall St. Rank hold PBH as of Q4 2016.

  • HBK Investments reported no remaining Prestige Consumer Healthcare position as of Q4 2016 after selling out during the quarter.
  • HBK Investments sold 39,500 Prestige Consumer Healthcare shares in Q4 2016, an estimated $1.91M.
  • HBK Investments first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 9 quarters.
  • HBK Investments's Prestige Consumer Healthcare position peaked at $1.91M in Q3 2016.
  • 238 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2016.

Based on HBK Investments's 13F filing for Q4 2016, filed 14 Feb 2017.